Wei Hong - Net Worth and Insider Trading

Wei Hong Net Worth

The estimated net worth of Wei Hong is at least $4 Million dollars as of 2024-11-07. Wei Hong is the Executives of Hybio Pharmaceutical Co Ltd and owns about 305,000 shares of Hybio Pharmaceutical Co Ltd (SZSE:300199) stock worth over $4 Million. Details can be seen in Wei Hong's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wei Hong has not made any transactions after 2019-07-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Wei Hong

To

Wei Hong Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wei Hong owns 1 companies in total, including Hybio Pharmaceutical Co Ltd (SZSE:300199) .

Click here to see the complete history of Wei Hong’s form 4 insider trades.

Insider Ownership Summary of Wei Hong

Ticker Comapny Transaction Date Type of Owner
SZSE:300199 Hybio Pharmaceutical Co Ltd 2019-07-22 Executives

Wei Hong Latest Holdings Summary

Wei Hong currently owns a total of 1 stock. Wei Hong owns 305,000 shares of Hybio Pharmaceutical Co Ltd (SZSE:300199) as of July 22, 2019, with a value of $4 Million.

Latest Holdings of Wei Hong

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SZSE:300199 Hybio Pharmaceutical Co Ltd 2019-07-22 305,000 11.91 3,632,550

Holding Weightings of Wei Hong


Wei Hong Form 4 Trading Tracker

According to the SEC Form 4 filings, Wei Hong has made a total of 0 transactions in Hybio Pharmaceutical Co Ltd (SZSE:300199) over the past 5 years. The most-recent trade in Hybio Pharmaceutical Co Ltd is the acquisition of 55,000 shares on July 22, 2019, which cost Wei Hong around $459,250.

Insider Trading History of Wei Hong

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wei Hong Trading Performance

GuruFocus tracks the stock performance after each of Wei Hong's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wei Hong is -25.55%. GuruFocus also compares Wei Hong's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wei Hong within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Wei Hong's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Wei Hong

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.68 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -6.9 LIMIT LIMIT LIMIT LIMIT LIMIT

Wei Hong Ownership Network

Ownership Network List of Wei Hong

No Data

Ownership Network Relation of Wei Hong

Insider Network Chart

Wei Hong Owned Company Details

What does Hybio Pharmaceutical Co Ltd do?

Who are the key executives at Hybio Pharmaceutical Co Ltd?

Wei Hong is the Executives of Hybio Pharmaceutical Co Ltd. Other key executives at Hybio Pharmaceutical Co Ltd include Directors & Directors & and Executives Zhu Wen Feng , Executives Tao An Jin , and Directors & executives Yuan Jian Cheng .

Hybio Pharmaceutical Co Ltd (SZSE:300199) Insider Trades Summary

Over the past 18 months, Wei Hong made no insider transaction in Hybio Pharmaceutical Co Ltd (SZSE:300199). Other recent insider transactions involving Hybio Pharmaceutical Co Ltd (SZSE:300199) include a net sale of 4,014,600 shares made by Ceng Shao Gui , a net sale of 4,117,500 shares made by Ceng Shao Qiang , and a net sale of 439,000 shares made by Ceng Shao Bin .

In summary, during the past 3 months, insiders sold 0 shares of Hybio Pharmaceutical Co Ltd (SZSE:300199) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,571,100 shares of Hybio Pharmaceutical Co Ltd (SZSE:300199) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,571,100 shares.

Hybio Pharmaceutical Co Ltd (SZSE:300199)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Hybio Pharmaceutical Co Ltd Insider Transactions

No Available Data

Wei Hong Mailing Address

Above is the net worth, insider trading, and ownership report for Wei Hong. Currently GuruFocus does not have mailing address information for Wei Hong.